| Groundbreaking
research is taking place in the Garden State that offers
hope to millions suffering from debilitating conditions
such as spinal cord injury, cancer, Alzheimer’s Disease,
and HIV/AIDS. A panel of research scientists from academia,
the public sector and the biotech industry will reveal breakthroughs
that place us closer to finding cures and potentially isolating
genes that may cause many of these diseases. The role heredity
plays in disease, and the interplay between environment
and genetic propensity will be explored. Additionally, this
half-hour program will examine the burgeoning field of personalized
medicine in which pharmaceuticals are tailored to address
an individual’s genetic make-up. New developments
in the behavioral/addictive sciences reveal that an individual’s
biological/molecular basis affects behaviors. The development
of 3-D data bases promise to detect and regulate the spread
of disease will be considered, along with the role of biopharmaceutical
companies.
Kenneth Breslauer
|
Kenneth Moch
|
Sherrie Preische
|
Dr. Jay Tischfield
|
Guests:
- Kenneth Breslauer - Ph.D.,Dean, Life Sciences, Rutgers
Univ.
- Jay Tischfield - Ph.D., Prof., Dept. of Genetics, Rutgers
Univ.
- Sherrie Preische - Ph.D., Exec. Dir., NJ Commission
on Science & Technology
- Kenneth Moch - Pres. & CEO, Alteon Inc.
|
